Scientists hunt for blood clues to tame unpredictable swelling attacks
NCT ID NCT04963634
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to find biomarkers (measurable substances in the blood) that could help doctors diagnose bradykinin angioedema and predict how severe attacks might be. The condition causes sudden, unpredictable swelling, and current tests don't work well for all types. Researchers planned to compare blood proteins from patients with the condition to healthy people, but the study was stopped early after enrolling only one participant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACQUIRED BRADYKININ ANGIOEDEMA DUE TO C1 INHIBITOR DEFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hop Claude Huriez Chu Lille
Lille, 59037, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.